Original Articles
1. Teillaud JL, Brunati S, Elmalek M, Astier A, Nicaise P, Moncuit J, Mathiot C, Job-Deslandre C and Fridman WH. Involvement of FcR + T cells and of IgG-BF in the control of myeloma cells. Mol. Immunol. 1990; 27: 1209-1217.
2. Cartron J, Celton JL, Gane P, Astier A, Fridman WH, Boissinot G and Cartron JP. Iso-immune neonatal neutropenia due to an anti-Fc receptor III (CD16) antibody. Eur. J. Pediatr. 1992; 151: 438-441.
3. Fridman WH, Teillaud JL, Bouchard C, Teillaud C, Astier A, Tartour E, Galon J, Mathiot C and Sautès C. Soluble Fcg receptors. J. Leukocytes Biol. 1993; 54: 504-512.
4. Astier A , de la Salle H, Freund M, Cazenave JP, Fridman WH, Hanau D and Teillaud JL. Detection and quantification of secreted soluble FcgRIIA in human sera by an Enzyme-Linked Immunosorbent Assay. J. Immunol. Methods 1993; 166: 1-10.
5. Teillaud JL, Bouchard C, Astier A, Teillaud C, Tartour E, Michon J, Galinha A, Moncuit J, Mazières N, Spagnoli R, Fridman WH and Sautès C. Natural and recombinant soluble low affinity FcgR: detection, purification and functional activities. Immunometh., 1994; 4; 48-64.
6. Astier A, de la Salle H, de la Salle C, Bieber T, Farese-Esposito ME, Freund M, Cazenave JP, Fridman WH, Teillaud JL and Hanau D. Human epidermal Langerhans cells secrete a soluble receptor for IgG (FcgRII/CD32) that inhibits the binding of immune complexes to FcgR + cells. J. Immunol. 1994; 152: 201-212.
7. Gachet C, Astier A, de la Salle H, Fridman WH, Cazenave JP, Teillaud JL and Hanau D. Soluble transmembrane-deleted FcgRIIA (FcgRIIa2) is released by human megacaryocyte cell lines and thrombin-activated human platelets and inhibits Fcg-mediated CD9-induced platelet aggregation. Blood 1995; 85: 698-704.
8. Manie S, Astier A, Wang D, Phifer JS, Chen J, Lazarovits AI, Morimoto C and Freedman AS. Stimulation of tyrosine phosphorylation after ligation of b7 and b1 integrins on human B cells. Blood 1996; 87: 1855-1861.
9. Manie S, Sattler M, Astier A, Wang D, Phifer JS, Chen J, Lazarovits AI, Morimoto C and Freedman AS. Tyrosine phosphorylation of the product of the c-cbl protooncogene is induced after integrin stimulation. Exp. Hematol.1996; 25: 45-50. 10. Astier A, Merle-Beral H, de la Salle H, Moncuit J, Cazenave JP, Fridman WH, Hanau D, Teillaud JL. Soluble Fc g receptor, Fc g RIIa2, exists under two forms in human serum and is increased in patients with stage C of B-Chronic lymphocytic leukemia. Leuk Lymphoma 1997; 26: 317-326.
11. Astier A, Avraham H, Manie SN, Groopman J, Druker BJ, Canty T, Avraham S and Freedman AS. The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated after b 1 integrin stimulation in B cells. J. Biol. Chem., 1997; 272: 228-232.
12. Manie S, Beck A, Astier A, Law SF , Canty T, Haghayeghi N, Druker BJ, Hirai H, Golemis EA and Freedman AS. Involvement of p130 cas and p105 HEF1, a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J. Biol. Chem., 1997; 272: 4230-4236.
13. Astier A, Manie SN, Law SF , Haghayeghi N, Canty T, Druker BJ, Salgia R, Golemis EA and Freedman AS. Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B cells. Possible relevance to neoplastic lymphohematopoietic cells. Leuk Lymphoma 1997; 28: 65-72.
14. Manie S, Astier A, Law SF, Haghayeghi N, Canty T, Hirai H and Freedman AS. Regulation of integrin-mediated tyrosine phosphorylation in human B cells: a role for p59 Fyn and SHP2. J Biol. Chem. 1997; 272: 15636-15641.
15. Astier A, Manié S, Avraham H, Hirai H, Law SF, Zhang Y, Golemis EA, Fu Y, Druker BJ, Haghayeghi N, Freedman AS and Avraham S. The related adhesion focal tyrosine kinase differentially phosphorylates p130 Cas and the Cas-like protein, p105 HEF1 . J. Biol. Chem. 1997; 272:19719-19724.
16. Vidalain PO, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C and Servet-Delprat C. Measles Virus Induces Functional TRAIL Production by Human Dendritic Cells. J. Virol. 2000; 74: 556-559.
17. Astier A, Trescol-Biemont MC, Azocar O, and Rabourdin-CombeC. Cutting edge: CD46, a new co-stimulatory molecule for T cells that induces p120 CBL and LAT phosphorylation. J Immunol. 2000; 64:6091-5.
18. Zaffran Y, Destaing O, Roux A, Ory S, Nheu T, Jurdic P, Rabourdin-CombeC and Astier AL. CD46/CD3 co-stimulation induces morphological changes of human T cells and activation of Vav, Rac and Erk MAPK. J Immunol, 2001; 167: 6780-5.
19. Marie JC, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF and Horvat B. Linking innate and acquired immunity: Divergent role of CD46 cytoplasmic domains in T cells induced inflammation. Nat Immunol. 2002; 3:659-66.
20. Astier AL, Xu R, Svoboda M, Hinds E, Munoz O, de Beaumont R, Crean CD, Gabig T, and Freedman AS Temporal gene expression profile of human B leukemia cells induced by adhesion receptor. Identification of pathways regulating B cells survival. Blood, 2003; 101:1118-27
21. Astier AL, Svoboda M, Hinds E, de Beaumont R, Munoz O, and Freedman AS. Integrins regulate survival of pre-B-ALL cells through differential IAP and caspase-7 ubiquitination and degradation . Leukemia, 2004; 18:873-5
22. Munoz O, Fend F, de Beaumont R, Husson H, Astier A, and Freedman AS. TGFbeta-mediated activation of Smad1 in B cell non-Hodgkin's lymphoma and effect on cell proliferation. Leukemia, 2004; 18:2015-25.
Review Articles
1. de la Salle H, Haegel-Kronenberger H, Bausinger H, Astier A, Cazenave JP, Fridman WH, Sautes C, Teillaud JL, Hanau D and Bieber T. (1997). Functions of Fc receptors on human dendritic Langerhans cells. Intern. Rev. Immunol., 16, 187-203.
2. Sautès C, Galon J, Bouchard C, Astier A, Teillaud JL and Fridman WH. (1998). Soluble Fc gR, a biological perspective. in"The immunoglobulin receptors and their physiological and pathological roles in immunity", ed: J. van de Winkel, Klewver Acad publisher. 24: 279-290.
